Opinion|Videos|June 19, 2024

Advancements in Alzheimer Disease Treatment: Emerging Drug Candidates

The panel discusses emerging therapies for Alzheimer disease that are currently in development, including donanemab, subcutaneous lecanemab, and ALZ-801.

Video content above is prompted by the following question(s):

  • Could you discuss disease modifying and other therapies for Alzheimer disease that are currently in development?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo